摘要
目的探讨血管内皮生长因子(VEGF)及成纤维细胞生长因子3(FGF3)在甲状腺良、恶性病变组织中的表达及其表达与甲状腺癌临床病理特征的关系。方法采用免疫组织化学S-P和SABC法检测61例甲状腺癌、43例甲状腺良性病变和19例癌旁组织标本的VEGF及FGF3的表达。结果甲状腺癌、甲状腺良性病变和癌旁组织VEGF阳性表达率分别为86.9%、16.3%、10.5%,FGF3阳性表达率分别为60.7%、7.0%及5.3%的,甲状腺癌与甲状腺良性病变和癌旁组织比较,VEGF及FGF3的阳性表达率均有显著性差异(P<0.05)。VEGF在甲状腺癌T3/T4期组、预后不良组及复发组的强阳性表达率均较对照组高(P<0.05),VEGF染色分数与甲状腺癌预后指数呈正相关(r=0.323,P=0.011);FGF3的表达与甲状腺癌组织学类型、肿瘤分期等临床病理参数无相关(P>0.05),但在VEGF阳性的甲状腺癌中有更高的表达(P<0.05)。结论VEGF及FGF3的过表达可作为协助甲状腺癌诊断的一个指标,两者在甲状腺癌中有协同表达;VEGF是甲状腺癌的预后预示因子。
Objective To investigate thc expression of VEGF and FGF3 gcnc product in bcnign and malignant thyroid diseases and cxplore thc relationship between thcir cxprcssion and thc clinicopathological fcaturcs of thyroid carcinoma. Methods The expression of VEGF and FGF3 wcrc dctermined by immunohistochcmistrical staining technique (S-P and SABC mcthod) in 61 cascs of thyroid carcinomas (containing 43 papillary, 14 follicular and 4 anaplastic carcinomas), 43 cases of hyperplastic lcsions(including 31 goiters and 12 thyroid adcnomas)and 19 adjacent tissue that had bccn fixcd in formalin and embedded in paraffin. Results Thc ratc of positive expression of VEGFwas 86.9%, 16.3% and 10. 5% while that of FGF3 was 60. 7%, 7, 0% and 5, 3% in tumor tissue, hyperplastic lesions and adjacent tissue, rcspcctivcly, The cxprcssion of VEGF and FGF3 was locatcd at cytoplasm and extracellular matrix; thc positivc cxprcssion and strong cxprcssion of VEGF and FGF3 were elcvated significantly in tumor tissue compared to hyperplastic lcsions and adjaccnt tissue; thc proportion of ovcr-cxprcssion of VEGF was statistically higher in patients at T3/T4 stagc, poor-prognostic and rccurrcncc patients compared to control cases (P〈0.05); thcrc was a positive corrclation bctwccn thc staining scorc of VEGF and the prognosis score of TC(r=0.323, P=0.011), On thc other hand, Thcrc was no significant diffcrcncc bctwcen the exprcssion of FGF3 and all of the clinicopathological features of thyroid canccr. Conclusion Thcrc is a positive relationship between the expression of VEGF and that of FGF3 in TC; the ovcrcxpression of VEGF and FGF3 is a auxiliary diagnosis marker for thyroid carcinoma. VEGF can bc used as a predictor for prognosis of TC; the ovcrexpression of VEGF in tumor tissue can predict lower differcntiation , greater aggrcssivc course and worsc prognosis.
出处
《西安交通大学学报(医学版)》
CAS
CSCD
北大核心
2005年第6期586-589,共4页
Journal of Xi’an Jiaotong University(Medical Sciences)
基金
广西自然科学基金资助项目(No.0447065)